Updated: March 12, 2026
Nivestym Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Learn about common and serious side effects of Nivestym (filgrastim-aafi), which ones are expected, which require a doctor call, and how to manage them during cancer treatment.
Nivestym (filgrastim-aafi) is an effective medication for preventing life-threatening infections in patients with neutropenia, but like all medications, it comes with potential side effects. Knowing what to expect — and what to watch out for — helps you stay safe and get the most out of your treatment.
This guide covers both common and serious side effects of Nivestym, and gives you clear guidance on when symptoms are manageable at home vs. when you need to call your doctor.
The Most Common Side Effect: Bone Pain
The most frequently reported side effect of Nivestym — and all filgrastim products — is bone pain, often felt in the lower back, hips, legs, or sternum (breastbone). This happens because Nivestym is stimulating your bone marrow to work harder and produce more white blood cells, and the rapid cell production creates pressure and inflammation inside the bones.
For most people, bone pain is mild to moderate and temporary — it typically peaks around the time your white blood cell count is rising and subsides as your ANC stabilizes. Over-the-counter non-opioid pain relievers (such as acetaminophen) may help. Avoid NSAIDs unless your oncologist approves them.
Common Side Effects of Nivestym
These side effects are generally expected and manageable with supportive care:
- Bone pain — Most common side effect; typically felt in the back, hips, and sternum
- Nausea and vomiting — May occur, especially when combined with chemotherapy
- Headache — Commonly reported; usually mild
- Fatigue — Especially during chemotherapy treatment periods
- Hair loss — Though this is more often related to chemotherapy itself
- Redness or soreness at the injection site — Normal with subcutaneous injections; rotate sites to minimize irritation
- Diarrhea — Reported in some patients
- Low platelet count (thrombocytopenia) — Your provider will monitor blood counts during treatment
Serious Side Effects: Call Your Doctor Immediately
These side effects are rare but can be life-threatening. Seek immediate medical attention if you experience any of the following:
- Splenic rupture: Pain in the upper left abdomen or left shoulder — this is a medical emergency. Nivestym can cause the spleen to enlarge and, in rare cases, rupture. Fatal cases have been reported.
- Acute Respiratory Distress Syndrome (ARDS): Fever with lung infiltrates or sudden difficulty breathing. Nivestym should be discontinued if ARDS develops.
- Serious allergic reactions (anaphylaxis): Hives, difficulty breathing, swelling of the face or throat. Most allergic reactions occur on first exposure. Nivestym must be permanently discontinued if a serious allergic reaction occurs.
- Sickle cell crisis: Patients with sickle cell disorders may experience severe and potentially fatal crises. Nivestym should be stopped immediately if sickle cell crisis occurs.
- Kidney injury (glomerulonephritis): Blood in urine, protein in urine, or decreased urination. Based on azotemia and hematuria in reported cases.
- Capillary Leak Syndrome (CLS): Low blood pressure, puffiness, and concentrated blood (high hematocrit). CLS can be life-threatening if not treated promptly.
- Cutaneous vasculitis: Purple spots or redness of the skin that doesn't go away with pressure — can indicate blood vessel inflammation.
- Leukocytosis (very high white blood cell count): WBC greater than 100,000/mm³. Your provider monitors for this; the dose may need to be reduced.
Long-Term Risk: MDS and AML in Congenital Neutropenia
For patients with congenital neutropenia receiving long-term filgrastim therapy, there is an association between treatment and the development of myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML). The risk appears to be confined to the subset of patients with congenital neutropenia and related to the underlying disease biology. If you or your child is being treated long-term for severe chronic neutropenia, your doctor will monitor for cytogenetic abnormalities and AML regularly.
Managing Bone Pain from Nivestym
Because bone pain is so common, here are practical tips for managing it:
- Take acetaminophen (Tylenol) as directed by your doctor for pain relief
- Apply a warm compress to painful areas for temporary relief
- Let your oncologist know if bone pain is severe — dose adjustments are sometimes made
- Avoid NSAIDs (ibuprofen, naproxen) unless your doctor specifically approves them — they may affect platelet function during chemotherapy
The Bottom Line
Bone pain is the side effect most patients experience with Nivestym, and it's generally manageable. However, serious side effects — splenic rupture, ARDS, anaphylaxis, and sickle cell crisis — require immediate medical attention. Always keep your oncology team informed of any new symptoms during treatment. And if you ever have trouble finding your prescription, medfinder can help locate pharmacies near you with Nivestym in stock. For more on medication safety, see our guide to Nivestym drug interactions.
Frequently Asked Questions
Bone pain is the most commonly reported side effect of Nivestym. It's caused by the bone marrow working harder to produce neutrophils. The pain is usually felt in the lower back, hips, legs, and sternum, and is typically mild to moderate. Acetaminophen can help; discuss all pain management options with your oncologist.
Seek immediate emergency care if you experience: pain in the upper left abdomen or left shoulder (possible splenic rupture), sudden difficulty breathing with fever (possible ARDS), hives or swelling of the face/throat (anaphylaxis), or extreme weakness or pain in a patient with sickle cell disease (sickle cell crisis). These are rare but potentially life-threatening.
For patients with congenital neutropenia receiving long-term filgrastim therapy, there is a known association with increased risk of myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML). This risk appears to be related to the underlying disease biology of congenital neutropenia. For cancer patients using Nivestym short-term during chemotherapy, this long-term cancer risk is not a primary concern.
Acetaminophen (Tylenol) is the most commonly recommended pain reliever for Nivestym-related bone pain. Warm compresses may also help. Avoid NSAIDs (ibuprofen, naproxen) unless your oncologist specifically approves them, as they can affect platelet function. If bone pain is severe, contact your oncologist — dose adjustments are sometimes possible.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Nivestym also looked for:
More about Nivestym
30,682 have already found their meds with Medfinder.
Start your search today.





